Heart and blood vessel health in myeloproliferative neoplasms
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study looks at heart and blood vessel problems in people with certain blood cancers called myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. It aims to understand how these conditions affect the heart and blood vessels, which may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with one of these blood conditions: essential thrombocythemia, polycythemia vera, or primary myelofibrosis.
- You are willing to take part in the study at Assiut University Hospital.
- You have not had a heart attack, stroke, heart failure, or high blood pressure before your blood condition was diagnosed.
- You do not have severe kidney or liver disease, another active cancer, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for specific immune system clues in patients with myeloproliferative neoplasms—rare blood disorders where your bone marrow produces too many blood cells. By identifying these markers, researchers hope to better understand and eventually treat these conditions.
This is a research registry for people who have certain blood cancers called myeloproliferative neoplasms (MPNs). It helps researchers learn about the disease over time and may help future studies find and compare patients.
This study looks at how pregnancy affects people with myeloproliferative neoplasms (MPNs), which are blood disorders that cause the body to make too many blood cells. It aims to learn more about outcomes for mothers and babies, and how to manage these conditions during pregnancy. You can join if you are pregnant and have an MPN.
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
Hear when a new Philadelphia Negative Myeloproliferative Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.